294 related articles for article (PubMed ID: 7850324)
21. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
[TBL] [Abstract][Full Text] [Related]
22. Late bacille Calmette-Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment.
Ströck V; Dotevall L; Sandberg T; Gustafsson CK; Holmäng S
BJU Int; 2011 May; 107(10):1592-7. PubMed ID: 21166754
[TBL] [Abstract][Full Text] [Related]
23. [Serious complications of intravesical bacillus Calmette-Guerin therapy in patients with bladder cancer].
Kudo S; Tsushima N; Sawada Y; Saito F; Motomura F; Takashima T; Kogawa T; Suzuki T; Kurotaki H; Masumori J
Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1594-602. PubMed ID: 1770698
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of Bacille Calmette-Guérin.
Morgan MB; Iseman MD
Am J Med; 1996 Mar; 100(3):372-3. PubMed ID: 8629686
[No Abstract] [Full Text] [Related]
25. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy with bacille Calmette-Guérin in patients with superficial transitional cell carcinoma of the bladder associated with bilharziasis.
Wishahi MM; Ismail IM; el-Sherbini M
Br J Urol; 1994 Jun; 73(6):649-54. PubMed ID: 8032832
[TBL] [Abstract][Full Text] [Related]
27. Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report.
Hakim S; Heaney JA; Heinz T; Zwolak RW
J Urol; 1993 Jul; 150(1):188-9. PubMed ID: 8510250
[TBL] [Abstract][Full Text] [Related]
28. The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma.
Böhle A; Rüsch-Gerdes S; Ulmer AJ; Braasch H; Jocham D
J Urol; 1996 Jun; 155(6):1892-6. PubMed ID: 8618281
[TBL] [Abstract][Full Text] [Related]
29. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
Aust TR; Massey JA
Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
[TBL] [Abstract][Full Text] [Related]
30. [BCG infection of the glans penis after intravesical BCG therapy].
Michelet N; Spenatto N; Viraben R; Cuny JF; Mazet J; Trechot P; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2008; 135(6-7):479-83. PubMed ID: 18598797
[TBL] [Abstract][Full Text] [Related]
31. Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group.
Akaza H; Hinotsu S; Aso Y; Kakizoe T; Koiso K
Cancer; 1995 Jan; 75(2):552-9. PubMed ID: 7812924
[TBL] [Abstract][Full Text] [Related]
32. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
[TBL] [Abstract][Full Text] [Related]
33. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
[TBL] [Abstract][Full Text] [Related]
34. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
Misra S; Gupta A; Symes A; Duncan J
Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
[TBL] [Abstract][Full Text] [Related]
35. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
[TBL] [Abstract][Full Text] [Related]
36. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
[TBL] [Abstract][Full Text] [Related]
37. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
[TBL] [Abstract][Full Text] [Related]
38. Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy.
LaFontaine PD; Middleman BR; Graham SD; Sanders WH
Urology; 1997 Mar; 49(3):363-6. PubMed ID: 9123699
[TBL] [Abstract][Full Text] [Related]
39. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
40. Sepsis and granulomatous hepatitis after bacillus Calmette-Guerin intravesical installation.
Trevenzoli M; Cattelan AM; Marino F; Sasset L; Donà S; Meneghetti F
J Infect; 2004 May; 48(4):363-4. PubMed ID: 15066339
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]